请输入您要查询的百科知识：

　

词条 TCF7L2
释义

  1. Function

  2. Structure

  3. Tissue Distribution

  4. Clinical significance

      Type 2 Diabetes    Gestational Diabetes (GDM)    Cancer    Schizophrenia    Multiple Sclerosis  

  5. Model organisms

  6. Nomenclature

  7. See also

  8. References

  9. Further reading

  10. External links

{{Infobox_gene}}Transcription factor 7-like 2 (T-cell specific, HMG-box) also known as TCF7L2 or TCF4 is a protein acting as a transcription factor that in humans, is encoded by the TCF7L2 gene.[1][2] The TCF7L2 gene is located on chromosome 10q25.2-q25.3, contains 19 exons, and has autosomal dominant inheritance.[3][4] The TCF7L2 gene is polymorphic and pleiotropic.[5] As a member of the TCF family, TCF7L2 can form a bipartite transcription factor and influence several biological pathways, including the Wnt signalling pathway.[6] The single nucleotide polymorphism (SNP) within the TCF7L2 gene, rs7903146, is, to date, the most significant genetic marker[6] associated with Type 2 diabetes mellitus (T2DM) risk. SNPs in this gene are especially known to be linked to higher risk to develop type 2 diabetes,[7] gestational diabetes,[9] and multiple other diseases.[8][11][12]

Function

TCF7L2 is a transcription factor influencing the transcription of several genes thereby exerting a large variety of functions within the cell. It is a member of the TCF family that can form a bipartite transcription factor (β-catenin/TCF) alongside β-catenin.[7] Bipartite transcription factors can have large effects on the Wnt signalling pathway.[7] Stimulation of the Wnt signaling pathway leads to the association of β-catenin with BCL9, translocation to the nucleus, and association with TCF7L2,[10] which in turn results in the activation of Wnt target genes. The activation of the Wnt target genes specifically represses proglucagon synthesis in enteroendocrine cells.[7][4] The repression of TCF7L2 using HMG-box repressor (HBP1) inhibits Wnt signalling.[7] Therefore, TCF7L2 is an effector in the Wnt signalling pathway. TCF7L2's role in glucose metabolism is expressed in many tissues such as gut, brain, liver, and skeletal muscle. However, TCF7L2 does not directly regulate glucose metabolism in β-cells, but regulates glucose metabolism in pancreatic and liver tissues.[11]

The TCF7L2 gene encoding the TCF7L2 transcription factor, exhibits multiple functions through its polymorphisms and thus, is known as a pleiotropic gene. Type 2 diabetes T2DM susceptibility is exhibited in carriers of TCF7L2 rs7903146C>T[12][5] and rs290481T>C[5] polymorphisms.[12][5] TCF7L2 rs290481T>C polymorphism, however, has shown no significant correlation to the susceptibility to gestational diabetes mellitus (GDM) in a Chinese Han population, whereas the T alleles of rs7903146[5] and rs1799884[13] increase susceptibility to GDM in the Chinese Han population.[5][13] The difference in effects of the different polymorphisms of the gene indicate that the gene is indeed pleiotropic.

Structure

The TCF7L2 gene, encoding the TCF7L2 protein, is located on chromosome 10q25.2-q25.3. The gene contains 19 exons and has autosomal dominant inheritance.[3][4] Of the 19 exons, 5 are alternative.[4] The TCF7L2 gene contains 619 amino acids and its molecular mass is 67919 Da.[14] TCF7L2's secondary structure is a helix-turn-helix structure.[15]

Tissue Distribution

TCF7L2 does not primarily operate in the β-cells in the pancreas.[16] It is also expressed in brain, liver, intestine, and fat cells.[16]

Clinical significance

Type 2 Diabetes

Several single nucleotide polymorphisms within the TCF7L2 gene have been associated with type 2 diabetes. Studies conducted by Ravindranath Duggirala and Michael Stern at The University of Texas Health Science Center at San Antonio were the first to identify strong linkage for type 2 diabetes at a region on Chromosome 10 in Mexican Americans [17] This signal was later refined by Struan Grant and colleagues at DeCODE genetics and isolated to the TCF7L2 gene.[18] The molecular and physiological mechanisms underlying the association of TCF7L2 with type 2 diabetes are under active investigation, but it is likely that TCF7L2 has important biological roles in multiple metabolic tissues, including the pancreas, liver and adipose tissue.[16][19] TCF7L2 polymorphisms can increase susceptibility to type 2 diabetes by decreasing the production of glucagon-like peptide-1 (GLP-1).[7]

Gestational Diabetes (GDM)

TCF7L2 modulates pancreatic islet β-cell function strongly implicating its significant association with GDM risk.[13] T alleles of rs7903146[5] and rs1799884[13] TCF7L2 polymorphisms increase susceptibility to GDM in the Chinese Han population.[5][13]

Cancer

TCF7L2 plays a role in colorectal cancer.[8] A frameshift mutation of TCF7L2 provided evidence that TCF7L2 is implicated in colorectal cancer.[20][21] The silencing of TCF7L2 in KM12 colorectal cancer cells provided evidence that TCF7L2 played a role in proliferation and metastasis of cancer cells in colorectal cancer.[8]

Variants of the gene are most likely involved in many other cancer types.[22] TCF7L2 is indirectly involved in prostate cancer through its role in activating the PI3K/Akt pathway, a pathway involved in prostate cancer.[23]

Schizophrenia

Single nucleotide polymorphisms (SNPs) in TCF7L2 gene have shown an increase in susceptibility to schizophrenia in Arab, European and Chinese Han populations.[24] In the Chinese Han population, SNP rs12573128[24] in TCF7L2 is the variant that was associated with an increase in schizophrenia risk. This marker is used as a pre-diagnostic marker for schizophrenia.[24]

Multiple Sclerosis

TCF7L2 is downstream of the WNT/β-catenin pathways. The activation of the WNT/β-catenin pathways have been associated demyelination in multiple sclerosis.[12] TCF7L2 is unregulated during early remyelination, leading scientists to believe that it is involved in remyelination.[12] TCF7L2 could act in dependence or independent of the WNT/β-catenin pathways.[25]

Model organisms

Model organisms have been used in the study of TCF7L2 function. A conditional knockout mouse line called Tcf7l2tm1a(EUCOMM)Wtsi was generated at the Wellcome Trust Sanger Institute.[26] Male and female animals underwent a standardized phenotypic screen[27] to determine the effects of deletion.[28][29][30][31] Additional screens performed: - In-depth immunological phenotyping[32]

Variations of the protein encoding gene are found in rats, zebra fish, drosophila, and budding yeast.[33] Therefore, all of those organisms can be used as model organisms in the study of TCF7L2 function. {{clear|left}}

Nomenclature

TCF7L2 is the symbol officially approved by the HUGO Gene Nomenclature Committee for the transcription factor 4 gene (TCF4).

See also

  • TCF/LEF family
{{clear}}

References

1. ^{{cite web | title = Entrez Gene: TCF7L2 | url =https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=6934 }}
2. ^{{cite journal | vauthors = Castrop J, van Norren K, Clevers H | title = A gene family of HMG-box transcription factors with homology to TCF-1 | journal = Nucleic Acids Research | volume = 20 | issue = 3 | pages = 611 | date = February 1992 | pmid = 1741298 | pmc = 310434 | doi = 10.1093/nar/20.3.611 }}
3. ^1 {{cite web|url=https://www.ncbi.nlm.nih.gov/gene/6934|title=TCF7L2 transcription factor 7 like 2 [Homo sapiens (human)] - Gene - NCBI|website=www.ncbi.nlm.nih.gov|access-date=2017-11-30}}
4. ^1 2 3 {{OMIM|602228|TRANSCRIPTION FACTOR 7-LIKE 2;TCF7L2 }}{
5. ^1 2 3 4 5 6 7 {{cite journal | vauthors = Zhu L, Xie Z, Lu J, Hao Q, Kang M, Chen S, Tang W, Ding H, Chen Y, Liu C, Wu H | title = TCF7L2 rs290481 T>C polymorphism is associated with an increased risk of type 2 diabetes mellitus and fasting plasma glucose level | journal = Oncotarget | volume = 8 | issue = 44 | pages = 77000–77008 | date = September 2017 | pmid = 29100364 | pmc = 5652758 | doi = 10.18632/oncotarget.20300 }}
6. ^{{cite journal | vauthors = Vaquero AR, Ferreira NE, Omae SV, Rodrigues MV, Teixeira SK, Krieger JE, Pereira AC | title = Using gene-network landscape to dissect genotype effects of TCF7L2 genetic variant on diabetes and cardiovascular risk | journal = Physiological Genomics | volume = 44 | issue = 19 | pages = 903–14 | date = October 2012 | pmid = 22872755 | doi = 10.1152/physiolgenomics.00030.2012 }}
7. ^1 2 3 4 5 6 {{cite journal | vauthors = Jin T, Liu L | title = The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus | journal = Molecular Endocrinology | volume = 22 | issue = 11 | pages = 2383–92 | date = November 2008 | pmid = 18599616 | doi = 10.1210/me.2008-0135 }}
8. ^1 2 {{cite journal | vauthors = Torres S, García-Palmero I, Marín-Vicente C, Bartolomé RA, Calviño E, Fernández-Aceñero MJ, Casal JI | title = Proteomic Characterization of Transcription and Splicing Factors Associated with a Metastatic Phenotype in Colorectal Cancer | journal = Journal of Proteome Research | date = November 2017 | pmid = 29131639 | doi = 10.1021/acs.jproteome.7b00548 | volume=17 | issue = 1 | pages=252–264}}
9. ^{{PDB|2GL7}}; {{cite journal | vauthors = Sampietro J, Dahlberg CL, Cho US, Hinds TR, Kimelman D, Xu W | title = Crystal structure of a beta-catenin/BCL9/Tcf4 complex | journal = Molecular Cell | volume = 24 | issue = 2 | pages = 293–300 | date = October 2006 | pmid = 17052462 | doi = 10.1016/j.molcel.2006.09.001 }}
10. ^{{cite journal | vauthors = Lee JM, Dedhar S, Kalluri R, Thompson EW | title = The epithelial-mesenchymal transition: new insights in signaling, development, and disease | journal = The Journal of Cell Biology | volume = 172 | issue = 7 | pages = 973–81 | date = March 2006 | pmid = 16567498 | pmc = 2063755 | doi = 10.1083/jcb.200601018 }}
11. ^{{cite journal | vauthors = Facchinello N, Tarifeño-Saldivia E, Grisan E, Schiavone M, Peron M, Mongera A, Ek O, Schmitner N, Meyer D, Peers B, Tiso N, Argenton F | title = Tcf7l2 plays pleiotropic roles in the control of glucose homeostasis, pancreas morphology, vascularization and regeneration | journal = Scientific Reports | volume = 7 | issue = 1 | pages = 9605 | date = August 2017 | pmid = 28851992 | pmc = 5575064 | doi = 10.1038/s41598-017-09867-x | bibcode = 2017NatSR...7.9605F }}
12. ^1 {{cite journal | vauthors = Chen Y, Zhao Y, Li YB, Wang YJ, Zhang GZ | title = Detection of SNPs of T2DM susceptibility genes by a ligase detection reaction-fluorescent nanosphere technique | journal = Analytical Biochemistry | volume = 540–541 | issue = Supplement C | pages = 38–44 | date = January 2018 | pmid = 29128291 | doi = 10.1016/j.ab.2017.11.003 }}
13. ^1 2 3 4 5 {{cite journal | vauthors = Zhang C, Bao W, Rong Y, Yang H, Bowers K, Yeung E, Kiely M | title = Genetic variants and the risk of gestational diabetes mellitus: a systematic review | journal = Human Reproduction Update | volume = 19 | issue = 4 | pages = 376–90 | date = 2013-05-19 | pmid = 23690305 | pmc = 3682671 | doi = 10.1093/humupd/dmt013 }}
14. ^{{Cite web|url=https://www.genecards.org/cgi-bin/carddisp.pl?gene=TCF7L2|title=TCF7L2 Gene - GeneCards {{!}} TF7L2 Protein {{!}} TF7L2 Antibody|last=Database|first=GeneCards Human Gene|website=www.genecards.org|access-date=2017-11-30}}
15. ^{{Cite web|url=https://www.uniprot.org/uniprot/Q9NQB0|title=TCF7L2 - Transcription factor 7-like 2 - Homo sapiens (Human) - TCF7L2 gene & protein|website=www.uniprot.org|language=en|access-date=2017-11-30}}
16. ^1 2 {{cite journal | vauthors = Nobrega MA | title = TCF7L2 and glucose metabolism: time to look beyond the pancreas | journal = Diabetes | volume = 62 | issue = 3 | pages = 706–8 | date = March 2013 | pmid = 23431017 | pmc = 3581232 | doi = 10.2337/db12-1418 }}
17. ^{{cite journal | vauthors = Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, O'Connell P, Stern MP | title = Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans | journal = American Journal of Human Genetics | volume = 64 | issue = 4 | pages = 1127–40 | date = April 1999 | pmid = 10090898 | pmc = 1377837 | doi=10.1086/302316}}
18. ^{{cite journal | vauthors = Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, Styrkarsdottir U, Magnusson KP, Walters GB, Palsdottir E, Jonsdottir T, Gudmundsdottir T, Gylfason A, Saemundsdottir J, Wilensky RL, Reilly MP, Rader DJ, Bagger Y, Christiansen C, Gudnason V, Sigurdsson G, Thorsteinsdottir U, Gulcher JR, Kong A, Stefansson K | title = Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes | journal = Nature Genetics | volume = 38 | issue = 3 | pages = 320–3 | date = March 2006 | pmid = 16415884 | pmc = | doi = 10.1038/ng1732 }}
19. ^{{cite journal | vauthors = Jin T | title = Current Understanding on Role of the Wnt Signaling Pathway Effector TCF7L2 in Glucose Homeostasis | journal = Endocrine Reviews | volume = 37 | issue = 3 | pages = 254–77 | date = June 2016 | pmid = 27159876 | pmc = | doi = 10.1210/er.2015-1146 }}
20. ^{{cite journal | vauthors = Slattery ML, Folsom AR, Wolff R, Herrick J, Caan BJ, Potter JD | title = Transcription factor 7-like 2 polymorphism and colon cancer | journal = Cancer Epidemiology, Biomarkers & Prevention | volume = 17 | issue = 4 | pages = 978–82 | date = April 2008 | pmid = 18398040 | pmc = 2587179 | doi = 10.1158/1055-9965.EPI-07-2687 }}
21. ^{{cite journal | vauthors = Hazra A, Fuchs CS, Chan AT, Giovannucci EL, Hunter DJ | title = Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk | journal = Cancer Causes & Control | volume = 19 | issue = 9 | pages = 975–80 | date = November 2008 | pmid = 18478343 | pmc = 2719293 | doi = 10.1007/s10552-008-9164-3 }}
22. ^{{cite journal | vauthors = Tang W, Dodge M, Gundapaneni D, Michnoff C, Roth M, Lum L | title = A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 105 | issue = 28 | pages = 9697–702 | date = July 2008 | pmid = 18621708 | pmc = 2453074 | doi = 10.1073/pnas.0804709105 | bibcode = 2008PNAS..105.9697T }}
23. ^{{cite journal | vauthors = Sun P, Xiong H, Kim TH, Ren B, Zhang Z | title = Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells | journal = Molecular Pharmacology | volume = 69 | issue = 2 | pages = 520–31 | date = February 2006 | pmid = 16291872 | doi = 10.1124/mol.105.019620 }}
24. ^1 2 3 {{cite journal | vauthors = Liu L, Li J, Yan M, Li J, Chen J, Zhang Y, Zhu X, Wang L, Kang L, Yuan D, Jin T | title = TCF7L2 polymorphisms and the risk of schizophrenia in the Chinese Han population | journal = Oncotarget | volume = 8 | issue = 17 | pages = 28614–28620 | date = April 2017 | pmid = 28404897 | pmc = 5438676 | doi = 10.18632/oncotarget.15603 }}
25. ^1 2 3 {{cite journal | vauthors = Vallée A, Vallée JN, Guillevin R, Lecarpentier Y | title = Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis | journal = Cellular and Molecular Neurobiology | volume = 38 | issue = 4 | pages = 783–795 | date = September 2017 | pmid = 28905149 | doi = 10.1007/s10571-017-0550-9 }}
26. ^{{cite journal |title=The Sanger Mouse Genetics Programme: high throughput characterisation of knockout mice | vauthors = Gerdin AK |year=2010 |journal=Acta Ophthalmologica|volume=88 |pages=925–7|doi=10.1111/j.1755-3768.2010.4142.x }}
27. ^{{cite web |url=http://www.mousephenotype.org/data/search?q=Tcf7l2#fq=**&facet=gene |title=International Mouse Phenotyping Consortium}}
28. ^{{cite journal | vauthors = Skarnes WC, Rosen B, West AP, Koutsourakis M, Bushell W, Iyer V, Mujica AO, Thomas M, Harrow J, Cox T, Jackson D, Severin J, Biggs P, Fu J, Nefedov M, de Jong PJ, Stewart AF, Bradley A | title = A conditional knockout resource for the genome-wide study of mouse gene function | journal = Nature | volume = 474 | issue = 7351 | pages = 337–42 | date = June 2011 | pmid = 21677750 | pmc = 3572410 | doi = 10.1038/nature10163 }}
29. ^{{cite journal | vauthors = Dolgin E | title = Mouse library set to be knockout | journal = Nature | volume = 474 | issue = 7351 | pages = 262–3 | date = June 2011 | pmid = 21677718 | doi = 10.1038/474262a }}
30. ^{{cite journal | vauthors = Collins FS, Rossant J, Wurst W | title = A mouse for all reasons | journal = Cell | volume = 128 | issue = 1 | pages = 9–13 | date = January 2007 | pmid = 17218247 | doi = 10.1016/j.cell.2006.12.018 }}
31. ^{{cite journal | vauthors = White JK, Gerdin AK, Karp NA, Ryder E, Buljan M, Bussell JN, Salisbury J, Clare S, Ingham NJ, Podrini C, Houghton R, Estabel J, Bottomley JR, Melvin DG, Sunter D, Adams NC, Tannahill D, Logan DW, Macarthur DG, Flint J, Mahajan VB, Tsang SH, Smyth I, Watt FM, Skarnes WC, Dougan G, Adams DJ, Ramirez-Solis R, Bradley A, Steel KP | title = Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes | journal = Cell | volume = 154 | issue = 2 | pages = 452–64 | date = July 2013 | pmid = 23870131 | pmc = 3717207 | doi = 10.1016/j.cell.2013.06.022 }}
32. ^{{cite web |url= http://www.immunophenotyping.org/data/search?keys=Tcf7l2&field_gene_construct_tid=All |title=Infection and Immunity Immunophenotyping (3i) Consortium}}
33. ^{{Cite web|url=http://marrvel.org/search/gene/TCF7L2|title=MARRVEL: Search Result|website=marrvel.org|access-date=2017-11-30}}

Further reading

{{refbegin|33em}}
  • {{cite journal | vauthors = Segditsas S, Tomlinson I | title = Colorectal cancer and genetic alterations in the Wnt pathway | journal = Oncogene | volume = 25 | issue = 57 | pages = 7531–7 | date = December 2006 | pmid = 17143297 | doi = 10.1038/sj.onc.1210059 }}
  • {{cite journal | vauthors = Florez JC | title = The new type 2 diabetes gene TCF7L2 | journal = Current Opinion in Clinical Nutrition and Metabolic Care | volume = 10 | issue = 4 | pages = 391–6 | date = July 2007 | pmid = 17563454 | doi = 10.1097/MCO.0b013e3281e2c9be }}
  • {{cite journal | vauthors = Maruyama K, Sugano S | title = Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides | journal = Gene | volume = 138 | issue = 1–2 | pages = 171–4 | date = January 1994 | pmid = 8125298 | doi = 10.1016/0378-1119(94)90802-8 }}
  • {{cite journal | vauthors = Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H | title = Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma | journal = Science | volume = 275 | issue = 5307 | pages = 1784–7 | date = March 1997 | pmid = 9065401 | doi = 10.1126/science.275.5307.1784 }}
  • {{cite journal | vauthors = Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S | title = Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library | journal = Gene | volume = 200 | issue = 1–2 | pages = 149–56 | date = October 1997 | pmid = 9373149 | doi = 10.1016/S0378-1119(97)00411-3 }}
  • {{cite journal | vauthors = He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW | title = Identification of c-MYC as a target of the APC pathway | journal = Science | volume = 281 | issue = 5382 | pages = 1509–12 | date = September 1998 | pmid = 9727977 | doi = 10.1126/science.281.5382.1509 | bibcode = 1998Sci...281.1509H }}
  • {{cite journal | vauthors = Barker N, Huls G, Korinek V, Clevers H | title = Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium | journal = The American Journal of Pathology | volume = 154 | issue = 1 | pages = 29–35 | date = January 1999 | pmid = 9916915 | pmc = 1853446 | doi = 10.1016/S0002-9440(10)65247-9 }}
  • {{cite journal | vauthors = Omer CA, Miller PJ, Diehl RE, Kral AM | title = Identification of Tcf4 residues involved in high-affinity beta-catenin binding | journal = Biochemical and Biophysical Research Communications | volume = 256 | issue = 3 | pages = 584–90 | date = March 1999 | pmid = 10080941 | doi = 10.1006/bbrc.1999.0379 }}
  • {{cite journal | vauthors = Giannini AL, Vivanco MM, Kypta RM | title = Analysis of beta-catenin aggregation and localization using GFP fusion proteins: nuclear import of alpha-catenin by the beta-catenin/Tcf complex | journal = Experimental Cell Research | volume = 255 | issue = 2 | pages = 207–20 | date = March 2000 | pmid = 10694436 | doi = 10.1006/excr.1999.4785 }}
  • {{cite journal | vauthors = Duval A, Busson-Leconiat M, Berger R, Hamelin R | title = Assignment of the TCF-4 gene (TCF7L2) to human chromosome band 10q25.3 | journal = Cytogenetics and Cell Genetics | volume = 88 | issue = 3–4 | pages = 264–5 | year = 2000 | pmid = 10828605 | doi = 10.1159/000015534 }}
  • {{cite journal | vauthors = Duval A, Rolland S, Tubacher E, Bui H, Thomas G, Hamelin R | title = The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines | journal = Cancer Research | volume = 60 | issue = 14 | pages = 3872–9 | date = July 2000 | pmid = 10919662 | doi = }}
  • {{cite journal | vauthors = Brantjes H, Roose J, van De Wetering M, Clevers H | title = All Tcf HMG box transcription factors interact with Groucho-related co-repressors | journal = Nucleic Acids Research | volume = 29 | issue = 7 | pages = 1410–9 | date = April 2001 | pmid = 11266540 | pmc = 31284 | doi = 10.1093/nar/29.7.1410 }}
  • {{cite journal | vauthors = Palacino JJ, Murphy MP, Murayama O, Iwasaki K, Fujiwara M, Takashima A, Golde TE, Wolozin B | title = Presenilin 1 regulates beta-catenin-mediated transcription in a glycogen synthase kinase-3-independent fashion | journal = The Journal of Biological Chemistry | volume = 276 | issue = 42 | pages = 38563–9 | date = October 2001 | pmid = 11504726 | doi = 10.1074/jbc.M105376200 }}
  • {{cite journal | vauthors = Miravet S, Piedra J, Miró F, Itarte E, García de Herreros A, Duñach M | title = The transcriptional factor Tcf-4 contains different binding sites for beta-catenin and plakoglobin | journal = The Journal of Biological Chemistry | volume = 277 | issue = 3 | pages = 1884–91 | date = January 2002 | pmid = 11711551 | doi = 10.1074/jbc.M110248200 | pmc = 5009259 }}
  • {{cite journal | vauthors = Graham TA, Ferkey DM, Mao F, Kimelman D, Xu W | title = Tcf4 can specifically recognize beta-catenin using alternative conformations | journal = Nature Structural Biology | volume = 8 | issue = 12 | pages = 1048–52 | date = December 2001 | pmid = 11713475 | doi = 10.1038/nsb718 }}
  • {{cite journal | vauthors = Poy F, Lepourcelet M, Shivdasani RA, Eck MJ | title = Structure of a human Tcf4-beta-catenin complex | journal = Nature Structural Biology | volume = 8 | issue = 12 | pages = 1053–7 | date = December 2001 | pmid = 11713476 | doi = 10.1038/nsb720 }}
  • {{cite journal | vauthors = Thiele A, Wasner M, Müller C, Engeland K, Hauschildt S | title = Regulation and possible function of beta-catenin in human monocytes | journal = Journal of Immunology | volume = 167 | issue = 12 | pages = 6786–93 | date = December 2001 | pmid = 11739494 | doi = 10.4049/jimmunol.167.12.6786 }}
  • {{cite journal | vauthors = Marchenko GN, Marchenko ND, Leng J, Strongin AY | title = Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin | journal = The Biochemical Journal | volume = 363 | issue = Pt 2 | pages = 253–62 | date = April 2002 | pmid = 11931652 | pmc = 1222473 | doi = 10.1042/0264-6021:3630253 }}
  • {{cite journal | vauthors = Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick R, Hanash S, Cho KR, Fearon ER | title = Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling | journal = The Journal of Biological Chemistry | volume = 277 | issue = 24 | pages = 21657–65 | date = June 2002 | pmid = 11940574 | doi = 10.1074/jbc.M200139200 }}
{{refend}}

External links

  • TCF7L2 here called TCF4 features on this Wnt pathway web site: Wnt signalling molecules TCFs
  • Structure determination of TCF7L2: PDB entry 2GL7 and related publication on [https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term=Crystal%20Structure%20of%20a%20beta-Catenin/BCL9/Tcf4%20Complex PubMed]
  • PubMed GeneRIFs (summaries of related scientific publications) - [https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=gene_full_report&db=gene&cmd=Display&dopt=gene_pubmed_rif&from_uid=6934]
  • Weizmann Institute GeneCard for [https://www.genecards.org/cgi-bin/carddisp.pl?gene=TCF7L2&search=tcf7l2 TCF7L2]
{{PDB Gallery|geneid=6934}}{{Signaling proteins}}{{Transcription factors|g4}}

3 : Transcription factors|Signal transduction|Gene expression
随便看

　

开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。

　

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间：2024/11/17 17:10:05